CUHK_CCT00004
2005-09-06
Retrospective
nil
Department of Obstetrics and Gynaecology
Nil
Nil
Chan Shing Chee, Symphorosa
Dept of O&G, PWH
2632 2583
symphorosa@cuhk.edu.hk
The Chinese University of Hong Kong
Chan Shing Chee, Symphorosa
symphorosa@cuhk.edu.hk
2632 2583
symphorosa@cuhk.edu.hk
The Chinese University of Hong Kong
Randomized Control Trial of Levo-norgestrel Intrauterine System in Women Receiving Tamoxifen for Carcinoma of Breast
Randomized Control Trial of Levo-norgestrel Intrauterine System in Women Receiving Tamoxifen for Carcinoma of Breast
Randomized Control Trial of Levo-norgestrel Intrauterine System in Women Receiving Tamoxifen for Car
Hong Kong
Yes
2001-03-20
Carcinoma of Breast on Tamoxifen
Device
Levo-norgestrel Intrauterine System (LNG-IUS, that is mirena)
5 years
Surveillance (with transvaginal ultrasound scan and outpatient hysteroscopy) for control group against Surveillance (TVS and outpatient hysteroscopy) and intervention with mirena insertion for the intervention group
Inclusion Criteria: 1. Patients with breast cancer using tamoxifen as an adjuvant therapy 2. Patients willing to give written consent to participate the study
Exclusion Criteria: 1. Patients with previous history of endometrial hyperplasia or endometrial carcinoma 2. Patients who are contraindicated to the use of LNG-IUS 3. Patients who have no intact uterus 4. Patients refuse to participate the study
18
nil
Female
Interventional
Randomized
Placebo
Open label
Parallel
2001-04-01
120
Complete
Endometrial pathology by hysteroscopy in both groups
Histology of endometrial pathology in both groups
2009-11-25
ChiCTR-TRC-09000625
2010-05-04
|
|
|
|
---|---|---|---|
No documents yet. |